Milot, M.-C.; Benesty, O.B.; Dumulon-Perreault, V.; Ait-Mohand, S.; Richard, P.O.; Rousseau, É.; Guérin, B.
64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window. Pharmaceuticals 2022, 15, 996.
https://doi.org/10.3390/ph15080996
AMA Style
Milot M-C, Benesty OB, Dumulon-Perreault V, Ait-Mohand S, Richard PO, Rousseau É, Guérin B.
64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window. Pharmaceuticals. 2022; 15(8):996.
https://doi.org/10.3390/ph15080996
Chicago/Turabian Style
Milot, Marie-Christine, Ophélie Bélissant Benesty, Véronique Dumulon-Perreault, Samia Ait-Mohand, Patrick O. Richard, Étienne Rousseau, and Brigitte Guérin.
2022. "64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window" Pharmaceuticals 15, no. 8: 996.
https://doi.org/10.3390/ph15080996
APA Style
Milot, M.-C., Benesty, O. B., Dumulon-Perreault, V., Ait-Mohand, S., Richard, P. O., Rousseau, É., & Guérin, B.
(2022). 64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window. Pharmaceuticals, 15(8), 996.
https://doi.org/10.3390/ph15080996